Healthy Returns: Wegovy is linked to an increased risk of hair loss, study suggests

Novo Nordisk’s weight loss drug Wegovy is linked to an increased risk of hair loss, a study suggests. Meanwhile, Dexcom received a warning letter from FDA…

Novo Nordisk’s weight loss drug Wegovy is linked to an increased risk of hair loss, a study suggests. Meanwhile, Dexcom received a warning letter from FDA…
Read More

About Author

Luz Buresh

See author's posts

Healthy Returns: Wegovy is linked to an increased risk of hair loss, study suggests

About Author

Luz Buresh

USDA, HHS Share Update on Dietary Guidelines for Americans Process

USDA Status Update on Probationary Employees

Why Dads Should Embrace Driving Their Kids to School

Minoryx doses first patient with leriglitazone in Rett syndrome study

Orphelia Pharma explores other pathways for paediatric cancer treatment

USDA, HHS Share Update on Dietary Guidelines for Americans Process

USDA Status Update on Probationary Employees

Healthy Returns: Wegovy is linked to an increased risk of hair loss, study suggests

Do food dyes make ADHD worse? What parents should know

Standard Glass Lining shares to debut today. Check GMP to know listing potential

FDA warns companies about lead contamination and other violations

J&J to buy psychiatric drug developer Intra-Cellular for $14.6B – BioPharma Dive

Three drug cocktail shows potential to boost CAR-T cancer therapy

Minoryx doses first patient with leriglitazone in Rett syndrome study

Orphelia Pharma explores other pathways for paediatric cancer treatment

USDA, HHS Share Update on Dietary Guidelines for Americans Process

USDA Status Update on Probationary Employees

Healthy Returns: Wegovy is linked to an increased risk of hair loss, study suggests

About PhaMed

Recent News

About Author

More Stories

You may have missed

About PhaMed

Recent News

Categories